Bank of Nova Scotia’s RAPT Therapeutics RAPT Stock Holding History

Bank of Nova Scotia’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,700	Closed	-$227K	–	1185
2025 Q4	$227K	Buy	+6,700	New	+$208K	﹤0.01%	1033

Bank of Nova Scotia's RAPT Position: Q1 2026 in Review

Bank of Nova Scotia sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 6,700 shares — an estimated $227K sold.

Bank of Nova Scotia first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $227K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Bank of Nova Scotia reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Bank of Nova Scotia sold 6,700 RAPT Therapeutics shares in Q1 2026, an estimated $227K.
Bank of Nova Scotia first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
Bank of Nova Scotia's RAPT Therapeutics position peaked at $227K in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.